Dr. Ellen Behrend received her VMD from the University of Pennsylvania School of Veterinary Medicine in 1988, followed by a one-year internship in Small Animal Medicine and Surgery at Michigan State University and then two years in private practice. Dr. Behrend finished both a residency in Small Animal Internal Medicine and a Master’s Degree at Colorado State University in 1994, and she completed a fellowship in Endocrinology in 1998 and a Ph.D. in 2001 from Auburn University. Dr. Behrend has served as a consultant for the Auburn University Endocrine Diagnostic Service since 1994 and VIN since 1998. She is currently the Joezy Griffin Professor in the Department of Clinical Sciences and an Auburn University Alumni Professor. She has authored or co-authored approximately 70 abstracts, 65 journal articles and 35 book chapters as well as serving as section editor for five textbook editions. Dr. Behrend is board-certified by the American College of Veterinary Internal Medicine (Small Animal Internal Medicine) and is a member of the College’s Board of Regents.

Dr. Whittemore graduated from the University of California, Davis College of Veterinary Medicine in 2000.  After two years in small animal general practice, she completed her residency in Internal Medicine and a PhD in Clinical Sciences at Colorado State University.  Her dissertation focused on evaluation of laboratory markers of systemic disease in dogs and cats.  She joined the faculty of the University of Tennessee in 2007 and enjoys balancing the demands of individual case management, teaching, and clinical research. Dr. Whittemore is an Associate Professor of Medicine at the University of Tennessee, College of Veterinary Medicine, where she also serves as the Minimally-Invasive Procedures service chief and the Acree Research Chair of Medicine.

Dr. Whittemore’s major research focus is on identification and amelioration of adverse effects of exogenous therapies on the gastrointestinal tract. Current work in this area is focused on adverse effects of antiplatelet, immunosuppressive and antibiotic therapies on the gastrointestinal tract and pancreas of dogs and cats. Secondary active areas of research include development and validation of veterinary simulators to minimize live animal use for veterinary training, for which she holds a patent, and development and validation of minimally-invasive interventional techniques to decrease patient morbidity and improve patient outcome.

Dr. Whittemore spends her free time building houses as a team leader for Habitat for Humanity, backpacking in the Smokies, and swing dancing.

Shelly J. Olin, DVM, DACVIM (SAIM), is an assistant professor at University of Tennessee, where she completed an internal medicine residency. Dr. Olin earned her DVM from and completed a rotating internship in small animal medicine and surgery at University of Georgia. She has also worked as an emergency veterinarian in Atlanta, Georgia. Her clinical interests are endocrinology, interventional procedures, and teaching.